european medicines agency glp-1 vision loss recommendation november 2025 Ozempic has 'very rare' sight side effect, EU drugs regulator finds – POLITICO No Link Between GLP-1 Drugs

The regions large and diverse population presents a significant opportunity for market expansion, especially as awareness of innovative weight loss therapies continues to rise

If you are still deciding whether a prescription weight loss program fits your goals, you can complete the free assessment quiz before taking your next step

The broader MDL addressing GLP1 drug injuries, including gastrointestinal and other systemic harms, reports over 3,000 total pending cases in federal court, reflecting continued claim growth across injury categories

$297/mo for monthly plans GLP-1 agonist 15% (68 weeks) 0.20 mg weekly 2.4 mg weekly Tirzepatide $332 / mo Billed Quarterly, Delivered Quarterly

87 LauJ.BlochP.SchafferL.PetterssonI.SpetzlerJ.KofoedJ.et al